Syros Pharmaceuticals, which in November said it would cut most of its workforce, is winding down operations and voluntarily delisting its stock from Nasdaq. Shares plunge 40% to 9 cents in ...

Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...

Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...

EST Syros Pharmaceuticals (SYRS) trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

EST Syros Pharmaceuticals (SYRS) trading halted, news pendingDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

The Seltos overall gains more value and the panoramic sunroof equipped model is under Rs 13 lakh. The variant line-up and the ...

Kia Syros introduces a range of innovative technologies, including a segment-first Over-the-Air (OTA) software update system.

The Kia Syros witnessed the customers preference towards the petrol-powered engine with 67 per cent of the total bookings, ...

The manual gearbox remains the preferred choice, while a considerable number of buyers opted for the automatic transmission ...

Kia India has made a strong start to 2025 with the launch of the Syros, its latest sub-compact SUV after the Sonet, which has ...

Kia has already seen over 20,000 interested buyers who have booked themselves brand-new Syros! Here is a look at the premium ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research ...